Literature DB >> 8902112

Experience with a hospital-wide outbreak of vancomycin-resistant enterococci.

J Quale1, D Landman, E Atwood, B Kreiswirth, B M Willey, V Ditore, M Zaman, K Patel, G Saurina, W Huang, E Oydna, S Burney.   

Abstract

BACKGROUND: Vancomycin-resistant enterococci (VRE) were first detected in our institution in 1991. An outbreak was recognized in late 1992 when there was a sudden rise in the number of patients per month with VRE. Little information exists concerning the natural history of infection with these pathogens, and the effect of antimicrobial therapy is unclear. Recent guidelines emphasize prudent use of vancomycin and prompt institution of barrier precautions to limit the spread of vancomycin resistance.
METHODS: Data were obtained by review of microbiologic and clinical records. Patients were categorized according to site of infection, and outcome of therapy was assessed. Hospital antibiotic usage was analyzed to determine any correlation with the outbreak. Infection control measures instituted in 1993 included patient isolation, environmental cleaning, and a reemphasis of barrier precautions. Surveillance cultures were performed to assess the extent of the outbreak in January 1995.
RESULTS: VRE were detected in clinical cultures from 159 patients from 1991 through 1994. Mortality rate was 48%, but in most cases death could not be attributed to enterococcal infection. Patients with wound infections healed without specific therapy. Many patients with bacteremia had resolution with ampicillin or without specific therapy. Patients were widely scattered throughout the hospital from the beginning of the outbreak. Hospital usage of cefotaxime correlated with the number of cases. Infection control measures were not successful. Surveillance culture results in January 1995 revealed that 53% of all medical and surgical inpatients had fecal colonization with VRE. Genetic analysis of selected isolates revealed that one strain predominated, but at least seven distinct strains were identified.
CONCLUSIONS: Our data suggest that many infections with VRE resolve without specific therapy. The infection control measures we used were ineffective, possibly because of the multiple strains present in our hospital. Isolation of all patients with VRE is impractical when there is widespread fecal carriage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902112     DOI: 10.1016/s0196-6553(96)90025-5

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  9 in total

Review 1.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 2.  Antibiotics and gastrointestinal colonization by vancomycin-resistant enterococci.

Authors:  L B Rice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 3.  Optimizing antibiotic therapy in the intensive care unit setting.

Authors:  M H Kollef
Journal:  Crit Care       Date:  2001-06-28       Impact factor: 9.097

4.  Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden.

Authors:  E Torell; O Cars; B Olsson-Liljequist; B M Hoffman; J Lindbäck; L G Burman
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

5.  Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patients.

Authors:  C W Hendrix; J M Hammond; S M Swoboda; W G Merz; S M Harrington; T M Perl; J D Dick; D M Borschel; P W Halczenko; R K Pelz; L E Rocco; J E Conway; R G Brower; P A Lipsett
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

6.  Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial.

Authors:  K G Shojania; D Yokoe; R Platt; J Fiskio; N Ma'luf; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1998 Nov-Dec       Impact factor: 4.497

Review 7.  Emergence of vancomycin-resistant enterococci.

Authors:  L B Rice
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

Review 8.  Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.

Authors:  Marin H Kollef
Journal:  Crit Care       Date:  2005-06-27       Impact factor: 9.097

9.  Antibiotic resistance patterns of bacterial isolates from blood in San Francisco County, California, 1996-1999.

Authors:  Susan S Huang; Brian J Labus; Michael C Samuel; Dairian T Wan; Arthur L Reingold
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.